HC Advisors LLC Sells 2,604 Shares of HealthEquity, Inc. (NASDAQ:HQY)

HC Advisors LLC decreased its holdings in shares of HealthEquity, Inc. (NASDAQ:HQY) by 22.4% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 9,030 shares of the company’s stock after selling 2,604 shares during the period. HealthEquity makes up about 0.7% of HC Advisors LLC’s holdings, making the stock its 22nd largest holding. HC Advisors LLC’s holdings in HealthEquity were worth $866,000 at the end of the most recent quarter.

Several other large investors also recently added to or reduced their stakes in the business. Louisiana State Employees Retirement System lifted its stake in HealthEquity by 0.4% during the fourth quarter. Louisiana State Employees Retirement System now owns 24,200 shares of the company’s stock worth $2,322,000 after purchasing an additional 100 shares during the last quarter. Oregon Public Employees Retirement Fund lifted its stake in HealthEquity by 0.6% during the fourth quarter. Oregon Public Employees Retirement Fund now owns 17,776 shares of the company’s stock worth $1,706,000 after purchasing an additional 100 shares during the last quarter. Raymond James Trust N.A. lifted its stake in HealthEquity by 4.8% during the third quarter. Raymond James Trust N.A. now owns 2,905 shares of the company’s stock worth $238,000 after purchasing an additional 132 shares during the last quarter. CIBC Asset Management Inc lifted its stake in HealthEquity by 5.6% during the fourth quarter. CIBC Asset Management Inc now owns 2,640 shares of the company’s stock worth $253,000 after purchasing an additional 139 shares during the last quarter. Finally, Sanctuary Advisors LLC lifted its stake in HealthEquity by 5.0% during the fourth quarter. Sanctuary Advisors LLC now owns 3,335 shares of the company’s stock worth $320,000 after purchasing an additional 159 shares during the last quarter. Institutional investors own 99.55% of the company’s stock.

HealthEquity Stock Up 1.4 %

Shares of NASDAQ:HQY opened at $107.05 on Friday. HealthEquity, Inc. has a 1 year low of $65.01 and a 1 year high of $115.59. The company has a market cap of $9.28 billion, a PE ratio of 98.21, a P/E/G ratio of 1.60 and a beta of 0.55. The company has a debt-to-equity ratio of 0.51, a current ratio of 3.20 and a quick ratio of 3.20. The stock’s 50-day moving average is $104.84 and its 200 day moving average is $93.08.

HealthEquity (NASDAQ:HQY) last announced its quarterly earnings results on Monday, December 9th. The company reported $0.59 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.71 by ($0.12). HealthEquity had a net margin of 8.41% and a return on equity of 9.70%. During the same period in the previous year, the company posted $0.40 EPS. Sell-side analysts anticipate that HealthEquity, Inc. will post 2.32 EPS for the current year.

Insiders Place Their Bets

In other HealthEquity news, Director Robert W. Selander sold 5,750 shares of the company’s stock in a transaction that occurred on Monday, February 10th. The stock was sold at an average price of $111.29, for a total transaction of $639,917.50. Following the transaction, the director now owns 78,219 shares in the company, valued at approximately $8,704,992.51. This represents a 6.85 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Stuart B. Parker sold 25,000 shares of the company’s stock in a transaction that occurred on Thursday, December 12th. The stock was sold at an average price of $96.72, for a total value of $2,418,000.00. Following the transaction, the director now owns 19,061 shares in the company, valued at $1,843,579.92. This trade represents a 56.74 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 39,000 shares of company stock worth $3,895,788. Company insiders own 2.20% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages have issued reports on HQY. The Goldman Sachs Group began coverage on HealthEquity in a research note on Friday, November 15th. They set a “neutral” rating and a $108.00 price target for the company. Raymond James lifted their price objective on HealthEquity from $105.00 to $120.00 and gave the stock an “outperform” rating in a report on Tuesday. JMP Securities lifted their price objective on HealthEquity from $105.00 to $107.00 and gave the stock a “market outperform” rating in a report on Tuesday, December 10th. Barrington Research lifted their price objective on HealthEquity from $105.00 to $120.00 and gave the stock an “outperform” rating in a report on Monday, December 2nd. Finally, Wells Fargo & Company lifted their price objective on HealthEquity from $110.00 to $125.00 and gave the stock an “overweight” rating in a report on Wednesday. One analyst has rated the stock with a hold rating and twelve have given a buy rating to the company. Based on data from MarketBeat, HealthEquity has an average rating of “Moderate Buy” and a consensus target price of $113.54.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.